These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 4138007)

  • 1. The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies.
    Michaelides MC; Eisen HN
    J Exp Med; 1974 Sep; 140(3):687-702. PubMed ID: 4138007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactions between 2, 4-dinitrophenyl and menadione (vitamin K3) and the general problem of antibody specificity.
    Johnston MF; Eisen HN
    J Immunol; 1976 Oct; 117(4):1189-96. PubMed ID: 789769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact regions for dinitrophenyl and menadione haptens in an immunoglobulin binding more than one antigen.
    Rosenstein RW; Musson RA; Armstrong MK; Konigsberg WH; Richards FF
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):877-81. PubMed ID: 4112641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--I. Estimation of distance by fluorescent energy transfer in protein 460.
    Manjula BN; Richards FF; Rosenstein RW
    Immunochemistry; 1976 Nov; 13(11):929-37. PubMed ID: 1010601
    [No Abstract]   [Full Text] [Related]  

  • 5. The distance between the contact sites for DNP and menadione ligands in the combining region of myeloma proteins binding both haptens--II. Estimation of distance using haptenic probes with variable length spacers.
    Rosenstein RW; Richards FF
    Immunochemistry; 1976 Nov; 13(11):939-43. PubMed ID: 1010602
    [No Abstract]   [Full Text] [Related]  

  • 6. Affinity labeling of the heavy and light chains of a myeloma protein with anti-2,4-dinitrophenyl activity.
    Haimovich J; Givol D; Eisen HN
    Proc Natl Acad Sci U S A; 1970 Dec; 67(4):1656-61. PubMed ID: 4099105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 2,4-dinitrophenyl derivatives by the light chain dimer obtained from immunoglobulin A produced by MOPC-315 mouse myeloma.
    Schechter I; Ziv E
    Biochemistry; 1976 Jun; 15(13):2785-90. PubMed ID: 820373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the fine specificity of anti-dinitrophenyl-combining site composed of either VL dimer or VL and VH of protein 315.
    Gavish M; Dwek RA; Givol D
    Biochemistry; 1977 Jul; 16(14):3154-9. PubMed ID: 70219
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody affinity. VIII. Measurement of affinity of anti-lactose antibody by fluorescence quenching with a DNP-containing ligand.
    Gopalakrishnan PV; Karush F
    J Immunol; 1975 Apr; 114(4):1359-62. PubMed ID: 1090676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resonance Raman-spectroscopic studies of the hapten features involved in the binding of 2,4-dinitrophenyl haptens by the mouse myeloma proteins MOPC 315 and MOPC 460.
    Kumar K; Phelps DJ; Carey PR; Young NM
    Biochem J; 1978 Nov; 175(2):727-35. PubMed ID: 743221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of epsilon-DNP-L-lysine exceeding two moles by purified chicken IgG anti-DNP antibody.
    Hoffmeister MJ; Voss EW
    Immunochemistry; 1974 Oct; 11(10):641-50. PubMed ID: 4617702
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.
    Dower SK; Gettins P; Jackson R; Dwek RA; Givol D
    Biochem J; 1978 Jan; 169(1):179-88. PubMed ID: 629744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding properties of bovine colostral anti-dinitrophenyl (dnp) immunoglobulins g2 (igg2).
    Mukkur TK; Fang WD
    Immunol Commun; 1976; 5(7-8):649-58. PubMed ID: 992704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.
    Merz DC; Litman GW; Good RA
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1940-4. PubMed ID: 4525470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.
    Dower SK; Wain-Hobson S; Gettins P; Givol D; Jackson WR; Perkins SJ; Sunderland CA; Sutton BJ; Wright CE; Dwek RA
    Biochem J; 1977 Aug; 165(2):207-23. PubMed ID: 921744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining sites of immunoglobulins that bind the 2,4-dinitrophenyl (DNP) group specifically.
    Haimovich J; Eisen HN; Givol D
    Ann N Y Acad Sci; 1971 Dec; 190():352-61. PubMed ID: 5290022
    [No Abstract]   [Full Text] [Related]  

  • 17. A human myeloma protein with specificity against dinitrophenyl and nucleic acid derivatives.
    Riesen W; Morell A
    Immunochemistry; 1972 Oct; 9(10):979-85. PubMed ID: 4673611
    [No Abstract]   [Full Text] [Related]  

  • 18. Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315.
    Wells JV; Fudenberg HH; Givol D
    Proc Natl Acad Sci U S A; 1973 May; 70(5):1585-7. PubMed ID: 4123072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies.
    Paul WE; Siskind GW; Benacerraf B
    J Exp Med; 1966 Apr; 123(4):689-705. PubMed ID: 4160399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.
    Katz DH; Paul WE; Goidl EA; Benacerraf B
    J Exp Med; 1970 Aug; 132(2):261-82. PubMed ID: 4101344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.